VH1-44 gene usage defines a subset of canine B-cell lymphomas associated with better patient survival

Veterinary Immunology and Immunopathology

Volumn 157, Issue 3-4, 2014, Pages 125-130

  Chen, Hsiao Wei ^a,b,c   Small, George W ^b,c   Motsinger Reif, Alison ^a   Suter, Steven E ^a,b,d   Richards, Kristy L ^a,b,c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

B cell lymphoma; Diffuse large B cell lymphoma; Immunoglobulin heavy chain variable region (VH); Survival; VH1 44

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CANCER PROGNOSIS; CANCER SURVIVAL; CANINE MODEL; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; EXPERIMENTAL DOG; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC SELECTION; GENETIC SIMILARITY; GERM LINE; HUMAN; LARGE CELL LYMPHOMA; MUTATIONAL ANALYSIS; NONHUMAN; OVERALL SURVIVAL; PREDICTION; PROGRESSION FREE SURVIVAL; SEQUENCE ANALYSIS; SOMATIC HYPERMUTATION; SURVIVAL TIME; VH1 44 GENE;

CANIS FAMILIARIS;

B-CELL LYMPHOMA; DIFFUSE LARGE B-CELL LYMPHOMA; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION (VH); SURVIVAL; VH1-44;

ANIMALS; DOG DISEASES; DOGS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA, B-CELL;

EID: 84893676399     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2013.10.020     Document Type: Article

References (23)

1. Arons E., Kreitman R.J. Molecular variant of hairy cell leukemia with poor prognosis. Leuk. Lymphoma 2011, 52(Suppl. 2):99-102.
2. Arons E., Suntum T., Stetler-Stevenson M., Kreitman R.J. VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood 2009, 114:4687-4695.
3. Bao Y., Guo Y., Xiao S., Zhao Z. Molecular characterization of the VH repertoire in Canis familiaris. Vet. Immunol. Immunopathol. 2010, 137:64-75.
4. Brezinschek H.P., Foster S.J., Brezinschek R.I., Dorner T., Domiati-Saad R., Lipsky P.E. Analysis of the human VH gene repertoire: differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J. Clin. Invest. 1997, 99:2488-2501.
5. Das S., Nozawa M., Klein J., Nei M. Evolutionary dynamics of the immunoglobulin heavy chain variable region genes in vertebrates. Immunogenetics 2008, 60:47-55.
6. Davis R.E., Brown K.D., Siebenlist U., Staudt L.M. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 2001, 194:1861-1874.
7. Deckmyn H., Zhang J., Van Houtte E., Vermylen J. Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIa. Blood 1994, 84:1968-1974.
8. Deng W., Nickle D.C., Learn G.H., Maust B., Mullins J.I. ViroBLAST: a stand-alone BLAST web server for flexible queries of multiple databases and user's datasets. Bioinformatics 2007, 23:2334-2336.
9. Elagib K.E., Tengner P., Levi M., Jonsson R., Thompson K.M., Natvig J.B., Wahren-Herlenius M. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjogren's syndrome. Arthritis Rheum. 1999, 42:2471-2481.
10. Fang Q., Kannapell C.C., Gaskin F., Solomon A., Koopman W.J., Fu S.M. Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of V lambda IIIb. J. Exp. Med. 1994, 179:1445-1456.
11. Gaurnier-Hausser A., Patel R., Baldwin A.S., May M.J., Mason N.J. NEMO-binding domain peptide inhibits constitutive NF-kappaB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma. Clin. Cancer Res. 2011, 17:4661-4671.
12. Hsu F.J., Levy R. Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood 1995, 86:3072-3082.
13. Marconato L., Gelain M.E., Comazzi S. The dog as a possible animal model for human non-Hodgkin lymphoma: a review. Hematol. Oncol. 2013, 31(1):1-9.
14. Lossos I.S., Alizadeh A.A., Eisen M.B., Chan W.C., Brown P.O., Botstein D., Staudt L.M., Levy R. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10209-10213.
15. Lossos I.S., Okada C.Y., Tibshirani R., Warnke R., Vose J.M., Greiner T.C., Levy R. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood 2000, 95:1797-1803.
16. Ponce F., Marchal T., Magnol J.P., Turinelli V., Ledieu D., Bonnefont C., Pastor M., Delignette M.L., Fournel-Fleury C. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Vet. Pathol. 2010, 47:414-433.
17. Richards K.L., Motsinger-Reif A.A., Chen H.W., Fedoriw Y., Fan C., Nielsen D.M., Small G.W., Thomas R., Smith C., Dave S.S., Perou C.M., Breen M., Borst L.B., Suter S.E. Gene profiling of canine B-cell lymphoma reveals germinal center and post-germinal center subtypes with different survival times, modeling human DLBCL. Cancer Res. 2013, 73:5029-5039.
18. Roark J.H., Bussel J.B., Cines D.B., Siegel D.L. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood 2002, 100:1388-1398.
19. Ruminy P., Etancelin P., Couronne L., Parmentier F., Rainville V., Mareschal S., Bohers E., Burgot C., Cornic M., Bertrand P., Lenormand B., Picquenot J.M., Jardin F., Tilly H., Bastard C. The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma. Leukemia 2011, 25:681-688.
20. Silberstein L.E., Jefferies L.C., Goldman J., Friedman D., Moore J.S., Nowell P.C., Roelcke D., Pruzanski W., Roudier J., Silverman G.J. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 1991, 78:2372-2386.
21. Stevenson F.K., Longhurst C., Chapman C.J., Ehrenstein M., Spellerberg M.B., Hamblin T.J., Ravirajan C.T., Latchman D., Isenberg D. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. J. Autoimmun. 1993, 6:809-825.
22. Walsh S.H., Rosenquist R. Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis. Med. Oncol. 2005, 22:327-341.
23. Walsh S.H., Thorselius M., Johnson A., Soderberg O., Jerkeman M., Bjorck E., Eriksson I., Thunberg U., Landgren O., Ehinger M., Lofvenberg E., Wallman K., Enblad G., Sander B., Porwit-MacDonald A., Dictor M., Olofsson T., Sundstrom C., Roos G., Rosenquist R. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood 2003, 101:4047-4054.